A risk-predictive model of gastric inflammation-cancer transformation based on the combination of disease and syndrome: a perspective study protocol
- Conditions
- Gastric cancer, Precancerous Lesions of Gastric Cancer
- Registration Number
- ITMCTR2024000089
- Lead Sponsor
- Hainan Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- Not specified
1. =35 years old; gender is not limited.
2. The diagnosis of chronic non-atrophic gastritis (CSG), chronic atrophic gastritis (CAG), precancerous lesions of gastric cancer (PLGC), and gastric adenocarcinoma (GC) is established through gastroscopy and examination of gastric mucosal pathology and histology.
3. It is possible to have effective communication.
4. Informed consent, voluntary participation.
1. Received drug treatment research within the past month.
2. The combination of autoimmune gastritis (Type A chronic atrophic gastritis), peptic ulcers (Stage A1-H2), gastroesophageal reflux disease, gastric polyps, hypertrophic gastritis, and ulcerative colitis.
3. Individuals with gastric cancer other than gastric adenocarcinoma include those with gastric signet ring cell carcinoma (SRCC), gastric cardia cancer (GCC), gastric mucinous cell carcinoma, etc.
4. Patients with malignant tumors who have undergone surgery, radiation therapy, or chemotherapy within the last 5 years.
5. Combination of severe organic illnesses, including cardiac conditions (NYHA class III-IV heart failure, hemodynamically unstable myocardial infarction, etc.), liver problems (cirrhosis, etc.), renal problems (chronic kidney failure, uremia, etc.), renal problems (chronic kidney failure, uremia, etc.), pulmonary diseases (tuberculosis, acute asthma attack, lung infection, etc.), and autoimmune disorders (systemic lupus erythematosus, etc.).
6. Allergies or multiple drug sensitivities.
7. People with concurrent serious mental disorders who are unable to participate in the study due to conditions such as schizophrenia, depression, anxiety, and dementia.
8. Existing pregnancy or breastfeeding.
9. Non-cooperative survey participants.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method